The Woleben family: Lauren, Doug, Will and Kasey (left to right). The family is eager to see a treatment for Will's ultra-rare disease. Courtesy photo
A biotech paused a gene therapy hatched by families. Now they want control
Will Woleben is like many 10-year-olds. He loves to watch sports and play jokes on his little sister. But Will can no longer walk, among …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
